MR. SALOMON ESQUENAZI, MD
Medical Practice at 37 Ave, Miami, FL
License number
Florida ME0090955
Category
Medical Practice
Type
Specialist
License number
Florida ME90955
Category
Medical Practice
Type
Ophthalmology
Address
Address
2441 SW 37Th Ave, Miami, FL 33145
Phone
(305) 442-0066
(305) 445-6896 (Fax)
(305) 445-6896 (Fax)
Personal information
See more information about SALOMON ESQUENAZI at radaris.comName
Address
Phone
1535 Cleveland Rd, Miami Beach, FL 33141
4100 N 43Rd Ave, Hollywood, FL 33021
6000 Island Blvd APT 906, Aventura, FL 33160
Hollywood, FL
102 Dunwoody Ln, Hollywood, FL 33021
Organization information
See more information about SALOMON ESQUENAZI at bizstanding.comSalomon Esquenazi MD
2441 SW 37 Ave, Miami, FL 33145
Industry:
Ophthalmology
Phone:
(305) 442-0066 (Phone)
Salomon Esquenazi
South Florida Eye Associate Pa - Salomon Esquenazi MD
800 S Douglas Rd STE 150, Coral Gables, FL 33134
Categories:
Ophthalmology Physicians & Surgeons
Phone:
(305) 461-0212 (Phone)
Professional information
See more information about SALOMON ESQUENAZI at trustoria.com
Salomon B. Esquenazi, P.a.
Salomon B. Esquenazi, P.a.
Position:
Manager at Rasco Klock Reininger Perez Esquenazi Vigil & Nieto
Location:
Miami/Fort Lauderdale Area
Industry:
Law Practice
Work:
Rasco Klock Reininger Perez Esquenazi Vigil & Nieto
-
Manager
Salomon Esquenazi, Miami FL
Salomon Esquenazi, Miami FL
Specialties:
Ophthalmologist
Address:
2441 Douglas Rd, Miami, FL 33145
Education:
Our Lady of the Rosary University, Faculty of Medicine - Doctor of Medicine
LSU Interim Hospital - Fellowship - Cornea and External Diseases
LSU Interim Hospital - Residency - Ophthalmology
Barraquer Clinic - Residency - Ophthalmologic Surgery
Ochsner Medical Center-New Orleans - Internship - Internal Medicine
LSU Interim Hospital - Fellowship - Cornea and External Diseases
LSU Interim Hospital - Residency - Ophthalmology
Barraquer Clinic - Residency - Ophthalmologic Surgery
Ochsner Medical Center-New Orleans - Internship - Internal Medicine
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology
Dr. Salomon Esquenazi, Coral Gables FL - MD (Doctor of Medicine)
Dr. Salomon Esquenazi, Coral Gables FL - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
Airala Laser/Cataract Institute
2441 S Douglas Rd, Coral Gables 33145
(305) 442-0066 (Phone)
2441 S Douglas Rd, Coral Gables 33145
(305) 442-0066 (Phone)
Certifications:
Ophthalmology, 2008
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Higher College of Our Lady of The Rosary / Faculty of Medicine
Ochsner Clinic Foundation
Barraquer Clinic
Lsu Medical Health Sciences Center
Higher College of Our Lady of The Rosary / Faculty of Medicine
Ochsner Clinic Foundation
Barraquer Clinic
Lsu Medical Health Sciences Center
Salomon B. Esquenazi, Coral Gables FL - Lawyer
Salomon B. Esquenazi, Coral Gables FL - Lawyer
Address:
283 Catalonia Ave FL 2, Coral Gables 33134
(305) 476-7100
Rasco Reininger & Perez P.A.
283 Catalonia Ave FL 2, Coral Gables 33134
(305) 476-7100
Rasco Reininger & Perez P.A.
283 Catalonia Ave FL 2, Coral Gables 33134
Licenses:
Florida - Member in Good Standing 1993
Texas - Not Eligible To Practice In Texas 1992
Texas - Not Eligible To Practice In Texas 1992
Education:
South Texas College of LawDegree JD - Juris Doctor - Law
Topical Treatment With Ngf And Dha In Damaged Corneas
Topical Treatment With Ngf And Dha In Damaged Corneas
US Patent:
2007021, Sep 20, 2007
Filed:
Sep 16, 2005
Appl. No.:
11/577239
Inventors:
Salomon Esquenazi - Aventura FL, US
Haydee Bazan - New Orleans LA, US
Nicolas Bazan - New Orleans FL, US
Haydee Bazan - New Orleans LA, US
Nicolas Bazan - New Orleans FL, US
International Classification:
A61K 38/18, A61F 9/00
US Classification:
424428000, 514002000
Abstract:
The topical administration of a combination of nerve growth factor (NGF) and docosahexaenoic acid (DHA) has been discovered to synergistically increase the effects of NGF in re-innervating the cornea. This enhancement in corneal nerve re-growth will yield a faster anatomical and functional recovery after PRK or LASIK surgeries. Using rabbits, the application of NGF and DHA resulted in increased corneal nerve surface area, increased epithelial proliferation, and decreased rose bengal staining as compared with NGF, DHA, or vehicle control individually. The topical application of NGF plus DHA in accelerating the re-innervation after PRK or LASIK, will help avoid or alleviate the symptoms of dry eye or other neurotrophic keratopathies due to corneal injuries. The topical application can be by using a corneal shield or lens. This treatment will also be useful in other corneal abnormalities including those caused by chemical burn, congenital corneal neuropathy, or acquired corneal neuropathy.